Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 12/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 7/20 | 0.43 |
| ▸ | HSP90AB1 | P08238 | 7/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15531890 | 0.97 | HPRT1 (0.47) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16625368 | 0.92 | HPRT1 (0.43) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL15532058 | 0.92 | HPRT1 (0.54) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16625355 | 0.91 | HPRT1 (0.48) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16625371 | 0.90 | HPRT1 (0.43) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16625367 | 0.90 | HPRT1 (0.54) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16627321 | 0.88 | HPRT1 (0.44) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16617868 | 0.88 | HPRT1 (0.58) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL16625364 | 0.88 | HPRT1 (0.45) | HPRT1HSP90AA1HSP90AB1 | |
| SCHEMBL15532457 | 0.87 | HPRT1 (0.42) | HPRT1HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200020-B2 | 6-oxopurine phosphoribosyltransferase inhibitors | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-01 | — | — | US | disclosed |
| US-20150099722-A1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099722-A1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | HPRT1, APRT, TPMT | HPRT1 1/4885HSP90AA1 2665/4885HSP90AB1 2234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.